Most cardiologists have been implicated in a malpractice lawsuit, according to Medscape’s annual Cardiologist Malpractice Report, and in many cases the litigation causes them to stop trusting their patients.
Rich people live an average of seven to nine more disability-free years than their socioeconomically disadvantaged peers, according to research published in the Journals of Gerontology: Medical Sciences Jan. 15.
Drugmaker AstraZeneca announced Jan. 6 that its SGLT2 inhibitor dapagliflozin, sold commercially as Farxiga, had been granted Priority Review by the FDA for patients with heart failure with reduced ejection fraction.
A New York cardiologist is suing tech giant Apple over its heartbeat-monitoring smartwatch capabilities, claiming the company lifted his patented HR intervention and has been using the technology without his permission.
The FDA has approved Amarin’s Vascepa—icosapent ethyl—to reduce cardiovascular risk beyond cholesterol-lowering therapy in high-risk patients, making it the first drug of its kind to be approved in the U.S.
The American Heart Association on Dec. 13 announced that it would be awarding more than $14 million in research grants to advance its new Strategically Focused Research Network on Cardiometabolic Health and Type 2 Diabetes.
At least 80 lawyers have been arrested after a violent altercation between attorneys and physicians left three patients dead at the Punjab Institute of Cardiology in Lahore, Pakistan, the New York Times reports.